Cannabidiol-monomethylether | 1972-05-0

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 异戊烯醇脂质
• 英文名称: Cannabidiol-monomethylether
• 英文别名: 3-Methoxy-2-(3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl)-5-pentylphenol
• CAS: 1972-05-0；41696-63-3
• 化学式: C₂₂H₃₂O₂
• 分子量: 328.495
• InChiKey: IPGGELGANIXRSX-UHFFFAOYSA-N

物化性质

• 沸点：
  418.0±45.0 °C(Predicted)
• 密度：
  0.988±0.06 g/cm3(Predicted)
• 溶解度：
  乙腈：10mg/mL；二甲基亚砜：30mg/mL

计算性质

• 辛醇/水分配系数(LogP)：
  6.8
• 重原子数：
  24
• 可旋转键数：
  7
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.55
• 拓扑面积：
  29.5
• 氢给体数：
  1
• 氢受体数：
  2

文献信息

• POLYFUNCTIONAL CANNABINOIDS
  申请人：Axim Biotechnologies, Inc.

  公开号：US20210332004A1

  公开（公告）日：2021-10-28

  This invention discloses cannabinoids linked with polyethylene glycol chains. The cannabinoid-polyethylene glycol chain molecules have one, two, or more cannabinoids linked with one, two, or more polyethylene glycol chains. Each cannabinoid-polyethylene glycol chain molecule may have one kind of cannabinoid or multiple kinds of cannabinoid. Methods to make these cannabinoid-polyethylene glycol linked chains are disclosed.

  这项发明揭示了与聚乙二醇链相连的大麻素。大麻素-聚乙二醇链分子具有一个、两个或更多个大麻素与一个、两个或更多个聚乙二醇链相连。每个大麻素-聚乙二醇链分子可能具有一种大麻素或多种大麻素。揭示了制造这些大麻素-聚乙二醇链的方法。
• Bio-stable cannabinoid compounds and methods for enhancing their physiological concentration
  申请人：Teewinot Technologies Limited

  公开号：US10384997B2

  公开（公告）日：2019-08-20

  The present disclosure provides biostable cannabinoid compounds according to Formula I: and methods for synthesizing and enhancing the biological concentrations of the compounds, where R1, R2, and R3 are defined as set forth in the disclosure.

  本公开提供了符合式 I 的生物稳定大麻素化合物： 以及合成和提高该化合物生物浓度的方法，其中 R1、R2 和 R3 的定义如本公开所述。
• BIO-STABLE CANNABINOID COMPOUNDS AND METHODS FOR ENHANCING THEIR PHYSIOLOGICAL CONCENTRATION
  申请人：Full Spectrum Laboratories Ltd.

  公开号：US20180201560A1

  公开（公告）日：2018-07-19

  The present disclosure provides biostable cannabinoid compounds according to Formula I: and methods for synthesizing and enhancing the biological concentrations of the compounds, where R 1 , R 2 , and R 3 are defined as set forth in the disclosure.
• [EN] CANNABIS OIL COMPOSITIONS AND METHODS FOR PREPARATION THEREOF<br/>[FR] COMPOSITIONS D'HUILE DE CANNABIS ET LEURS PROCÉDÉS DE PRÉPARATION
  申请人：CONSTANCE THERAPEUTICS INC

  公开号：WO2017091764A1

  公开（公告）日：2017-06-01

  The present invention provides cannabis oil compositions, including cannabis oil compositions containing vitamin E, and methods for preparing the cannabis oil compositions. In some embodiments, the invention provides a method for preparing a cannabis oil composition comprising eluting cannabinoids from cannabis plant material with a solvent to produce an eluate; filtering the eluate with a filter to produce a filtrate; evaporating the solvent from the filtrate with a distiller to produce a distillate; and purging the distillate under conditions sufficient to remove residual solvent. In some embodiments, the method further includes mixing a quantity of vitamin E with the extract. Blended cannabis oil compositions containing mixtures of cannabis oil preparations are also described.
• [EN] CONJUGATE MOLECULES<br/>[FR] MOLÉCULES CONJUGUÉES
  申请人：DIVERSE BIOTECH INC

  公开号：WO2021076197A1

  公开（公告）日：2021-04-22

  This disclosure provides multifunctional conjugate molecules comprising a target binding component covalently linked to one or more cannabinoids and/or one or more cannabinoid conjugate components. In some embodiments, the target binding component also is covalently linked to one or more active agent components. The disclosed conjugate molecules are designed to deliver therapeutic benefits of each component of the conjugate molecules and can be used to treat cancer and other disorders.